Recently, inhibition of PKC has been reported to prevent aggregation of α-synuclein, a key causative protein of PD, upon transfection with pre-aggregated ‘seed’ α-synuclein (Svanbergsson et al., 2021). Here, PRRT2 is linked to Parkinson disease.